Kidney Transplant Medication - enteric-coated myfortic mycophenolic acid delayed-release tablet





 

Featured Click - Quiz: How are you feeling?

 
  Novartis Pharma US

 






Click here for complete prescribing information, which includes contraindications, warnings, precautions, and adverse events.




CellCept® is a registered trademark of Roche Laboratories, Inc.
 

Important Safety Information

 


 

myfortic Home | Before a Kidney Transplant | After a Kidney Transplant Treatment Options: myfortic and CellCept | Life With myfortic 
 More Transplant Resources| For Women Of Child Bearing Age
Prescribing Information | Important Safety Information | For Healthcare Professionals Glossary | Site Guide | Site Map | Contact Us
Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2009
Novartis Pharmaceuticals Corporation. All rights reserved.